StockNews.com Initiates Coverage on Sorrento Therapeutics (NASDAQ:SRNE)

Equities researchers at StockNews.com initiated coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) in a research note issued to investors on Tuesday. The firm set a “hold” rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Price Performance Shares of NASDAQ:SRNE opened at $0.00 on Tuesday. Sorrento Therapeutics has a 12-month low of […]

Leave a Reply

Your email address will not be published.

Previous post Xunlei (NASDAQ:XNET) Stock Rating Lowered by StockNews.com
Next post Short Interest in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Declines By 5.4%